Overview
The current observational study aims to perform the sentinel lymph node in breast cancer in the usual way with technetium 99 and add a second tracer, indocyanine green. The objective is to evaluate the detection rate of the lymph node with indocyanine green compared to the usual technique.
Description
In the operating room 1 ml of indocyaninge grenn will be injectec periareolar . After 5 minutes the lymph node will be detected and extracted. The comparison between the lymph nodes detected with Technetium 99 and indocyanine green will be analysed.
Eligibility
Inclusion Criteria:
- Patients >18 years of age with breast cancer who are candidates for sentinel lymph node detection will be included.
- N0 patients or patients who have undergone target axillary detection with good response
Exclusion Criteria:
- Lymphadenectomy